Medincell (XPAR:MEDCL) Scaled Net Operating Assets : 0.36 (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Medincell Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Medincell's operating assets for the quarter that ended in Sep. 2023 was €23.71 Mil. Medincell's operating liabilities for the quarter that ended in Sep. 2023 was €13.01 Mil. Medincell's Total Assets for the quarter that ended in Mar. 2023 was €29.34 Mil. Therefore, Medincell's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was 0.36.

Medincell Scaled Net Operating Assets Historical Data

The historical data trend for Medincell's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Scaled Net Operating Assets Chart

Medincell Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.47

0.15

0.10

0.12

0.20

Medincell Semi-Annual Data
	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Scaled Net Operating Assets	Get a 7-Day Free Trial										0.11	0.14	0.19	0.27	0.37

Competitive Comparison of Medincell's Scaled Net Operating Assets

For the Biotechnology subindustry, Medincell's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medincell's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medincell's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Medincell's Scaled Net Operating Assets falls into.

Medincell Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Medincell's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2023 )
=	(Operating Assets (A: Mar. 2023 )	-	Operating Liabilities (A: Mar. 2023 ))	/	Total Assets (A: Mar. 2022 )
=	(22.872	-	13.925)	/	44.303
=	0.20

where

	Operating Assets		(A: Mar. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	29.339	-	6.467
=	22.872

	Operating Liabilities		(A: Mar. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	71.633	-	14.252	-	43.456
=	13.925

Medincell's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2023 )
=	(Operating Assets (Q: Sep. 2023 )	-	Operating Liabilities (Q: Sep. 2023 ))	/	Total Assets (Q: Mar. 2023 )
=	(23.711	-	13.006)	/	29.339
=	0.36

where

	Operating Assets		(Q: Sep. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	50.489	-	26.778
=	23.711

	Operating Liabilities		(Q: Sep. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	76.236	-	53.175	-	10.055
=	13.006

Medincell Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Medincell's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Medincell (XPAR:MEDCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (XPAR:MEDCL) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

MEB:Germany

Address

3 rue des Freres Lumiere, Jacou, FRA, 34830

Website

https://www.medincell.com

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell (XPAR:MEDCL) Headlines

No Headlines